Agilent Technologies Acquires e-MSion

Bruker Corporation Acquires Nion

January 3, 2024

Manufacturing

Bruker Corporation has acquired Nion, a Kirkland, Washington developer and manufacturer of high-end scanning transmission electron microscopes (STEM), including the UltraSTEM line and advanced EELS technology. The acquisition strengthens Bruker's materials science instrumentation portfolio and provides capabilities for electron diffraction crystallography; Nion reported approximately $8 million in revenue in 2023. Financial terms were not disclosed.

IonQ Acquires Oxford Ionics

September 17, 2025

AI & Machine Learning

IonQ has completed the acquisition of Oxford Ionics, a UK-based trapped-ion quantum systems company, to accelerate its technology roadmap and expand its presence in the United Kingdom and Europe. The deal adds Oxford Ionics' patented ion trap technology and engineering team to IonQ's hardware and software stack to help develop higher-fidelity, scalable quantum systems.

VION Biosciences Acquires Echelon Biosciences

August 22, 2024

Biotechnology

VION Biosciences, the life-science platform backed by Iron Path Capital, has acquired Salt Lake City-based Echelon Biosciences, a specialist supplier of lipid-based excipients and lipid nanoparticles. The add-on strengthens VION's capabilities in lipid synthesis and lipid nanoparticle technology to support mRNA and gene-therapy development and advances the platform toward drug manufacturing while keeping Echelon’s leadership and operations intact.

MHC Software Acquires Ecrion Software

June 22, 2020

Software

MHC Software has acquired Ecrion Software, a Rockville-based provider of customer communication management (CCM) and customer experience automation (CXA) software and services. The deal adds omnichannel communication, dynamic documents, and customer journey automation capabilities to MHC's enterprise automation platform and follows a prior majority investment in MHC by Strattam Capital.

Summa Equity Acquires Majority Stake in Axion BioSystems

July 15, 2021

Medical Devices

Summa Equity Fund II has acquired a majority stake in Axion BioSystems, a US life science tools company that develops MEA (microelectrode array) and impedance-based bioelectronic assay technologies. Summa plans to support Axion's commercial scale-up and global growth to accelerate adoption of its platforms across academia and biopharma, particularly in cell and gene therapy and drug discovery applications.

Cell Microsystems Acquires Fluxion Biosciences

August 23, 2023

Medical Devices

Durham-based Cell Microsystems has acquired Fluxion Biosciences, adding Fluxion's IonFlux, BioFlux and IsoFlux instruments and services to its CellRaft-based product portfolio. The deal is supported by a concurrent Series B financing led by Telegraph Hill Partners to provide growth capital and accelerate product and service integration for cellular analysis and electrophysiology workflows.